Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShor... by Ekqvist, David, Bornefall, Anna, Augustinsson, Daniel, Sönnerbrandt, Martina, Nordvall, Michaela Jonsson, Fredrikson, Mats, Carlsson, Björn, Sandstedt, Mårten, Simonsson, Ulrika S H, Alffenaar, Jan-Willem C, Paues, Jakob, Niward, Katarina

Get full text

A novel mycobacterial growth inhibition assay employing live-cell imaging of virulent M. tuberculosis and monitoring of host cell viability by Andersson, Blanka, Nordvall, Michaela Jonsson, Welin, Amanda, Lerm, Maria, Schön, Thomas

Get full text

Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuber... by Kuhlin, Johanna, Davies Forsman, Lina, Mansjö, Mikael, Jonsson Nordvall, Michaela, Wijkander, Maria, Wagrell, Charlotta, Jonsson, Jerker, Groenheit, Ramona, Werngren, Jim, Schön, Thomas, Bruchfeld, Judith

Get full text

Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting by Niward, Katarina, Davies Forsman, Lina, Bruchfeld, Judith, Chryssanthou, Erja, Carlström, Oskar, Alomari, Teba, Carlsson, Björn, Pohanka, Anton, Mansjö, Mikael, Jonsson Nordvall, Michaela, Johansson, Anders G, Eliasson, Erik, Werngren, Jim, Paues, Jakob, Simonsson, Ulrika S H, Schön, Thomas

Get full text

Genotypic resistance of pyrazinamide but not MIC is associated with longer time to sputum culture conversion in patients with multidrug-resistant tuberculosis by Kuhlin, Johanna, Davies Forsman, Lina, Mansjö, Mikael, Jonsson Nordvall, Michaela, Wijkander, Maria, Wagrell, Charlotta, Jonsson, Jerker, Groenheit, Ramona, Werngren, Jim, Schön, Thomas, Bruchfeld, Judith

Get full text